Acute myocardial infarction: a rare complication of protein C deficiency

AMERICAN JOURNAL OF MEDICINE VOL. 110, NO. 5; APRIL 1, 2001 CLINICAL STUDIES Physician interpretation of electrocardiographic artifact that mimics ventricular tachycardia Bradley P. Knight, Frank Pelosi, Gregory F. Michaud, S. Adam Strickberger, Fred Morady Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors Stella M. Davies, Todd E. DeFor, Phillip B. McGlave, Jeffrey S. Miller, Catherine M. Verfaillie, John E. Wagner, Daniel J. Weisdorf Declining rate of substance abuse throughout the month Scott D. Halpern, C. Crawford Mechem Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia Howard H. Knapp, Helmut Schrott, Patrick Ma, Robert Knopp, Bruce Chin, J. Michael Gaziano, Joanne M. Donovan, Steven K. Burke, Michael H. Davidson Prognostic value of pharmacologic stress echocardiography in patients with left bundle branch block Lauro Cortigiani, Eugenio Picano, Carlo Vigna, Fabio Lattanzi, Claudio Coletta, Egidio Mariotti, Riccardo Bigi, on behalf of the EPIC (Echo Persantine International Cooperative) and EDIC (Echo Dobutamine International Cooperative) Study Groups SPECIAL ARTICLES Electronic publishing of science: better late than never David Robertson Physician opinion about electronic publications Scott M. Wright, William T-C Tseng, Ken Kolodner REVIEW A systematic review of randomized trials of disease management programs in heart failure Finlay A. McAlister, Fiona M.E. Lawson, Koon K. Teo, Paul W. Armstrong PHYSIOLOGY IN MEDICINE Molecular biology and the prolonged QT syndromes Jeffrey A. Towbin, Matteo Vatta BRIEF OBSERVATION Guillain-Barr ésyndrome complicated with hemolytic anemia in association with antiganglioside GM3 antibody Koji Aoyama, Hiroto Ishikura, Seiji Mishima, Maiko Murai, Hiroto Tsumura, Shunichi Kumakura, Shotai Kobayashi CASE OF THE MONTH Case of the month A.S. Kashyap EDITORIALS

335 -- 338

339 -- 346

347 -- 351 352 -- 360

361 -- 369

370 -- 372 373 -- 377

378 -- 384

385 -- 398

399 -- 400

401 -- 401

Electrocardiography artifact: what you do not know, you do not recognize William G. Stevenson, William H. Maisel Treatment of chronic myeloid leukemia Patrick G. Beatty Relapse triggers-full moon, full wallet, or foolhardy? Jeffrey Samet Publishing at the speed of life Warren S. Browner Heart failure disease management programs: efficacy and limitations Michael W. Rich CORRESPONDENCE Vasculitis of the female genital tract Alexander Woywodt, Ursula Goebel Acute myocardial infarction: a rare complication of protein C deficiency Adnan Sadiq, Shahid Ahmed, Anita Karim, Jeffrey Spivak, Joseph Mattana Toilet seat syndrome: renal failure, perineal gangrene, and sciatic neuropathy Rajive Jassal, Davinder S. Jassal, John M. Embil Esophageal tuberculosis: a rare but not to be forgotten entity Sigurdur T. Sigurdarson, F. Jeffrey Field, Larry S. Schlesinger Acute myocardial infarction after aortic valve endocarditis Allen Jeremias, Ivan Casserly, J. Murray Estess, Nicholas G. Smedira, Eric J. Topol APM VIEWS Teaching students the art and science of physical diagnosis Ruric C. Anderson, Mark J. Fagan, James Sebastian

402 -- 403 404 -- 405 406 -- 407 408 -- 409 410 -- 412

413 -- 413 414 -- 414 414 -- 415

415 -- 416 417 -- 418

419 -- 423

VOL. 110, NO. SUPPLEMENT 1; 2001 OPTIMIZING USE OF β-BLOCKERS IN THE TREATMENT OF HEART FAILURE: A CASE STUDY APPROACH Introduction James B. Young Current utilization trends for -blockers in cardiovascular disease Harold L. Kennedy Clinical trials of β blockers in heart failure: a class review Clyde W. Yancy Optimizing the use of β blockers in the effective treatment and management of heart failure: a case study approach Eric J. Eichhorn, James B. Young

1 -- 1 2 -- 6 7 -- 10 11 -- 20

VOL. 110, NO. 6; APRIL 15, 2001 CLINICAL STUDIES Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction Michael G. Shlipak, Warren S. Browner, Haruko Noguchi, Barry Massie, Craig D. Frances, Mark McClellan

425 -- 433

The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria Cheuk-Chun Szeto, Fernand Mac-Moune Lai, Ka-Fai To, Teresa Yuk-Hwa Wong, Kai-Ming Chow, Paul Cheung-Lung Choi, Siu-Fai Lui, Philip KamTao Li Life-threatening hyperkalemia during combined therapy with angiotensinconverting enzyme inhibitors and spironolactone: an analysis of 25 cases Hans Schepkens, Raymond Vanholder, Jean-Marie Billiouw, Norbert Lameire Effects of hormone replacement therapy on clinical fractures and height loss: the heart and estrogen/progestin replacement study (HERS) Jane A. Cauley, Dennis M. Black, Elizabeth Barrett-Connor, Fran Harris, Kathleen Shields, William Applegate, Steven R. Cummings Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia Nathan C. Dean, Michael P. Silver, Kim A. Bateman, Brent James, Carol J. Hadlock, David Hale Outpatient treatment of deep venous thrombosis in diverse inner-city patients Andrew S. Dunn, Clyde Schechter, Andrew Gotlin, Despina Vomvolakis, Ellis Jacobs, Henry S. Sacks, Barry Coller SPECIAL ARTICLE Key challenges confronting internal medicine in the early twenty-first century Lee Goldman REVIEWS Formulating clinical strategies for angiotensin antagonism: a review of preclinical and clinical studies Raymond Tabibiazar, Aamer H. Jamali, Stanley G. Rockson Prospective studies of the safety of acupuncture: a systematic review Edzard Ernst, Adrian R. White BRIEF OBSERVATIONS Association of tumor necrosis factor-2 allele with plasma tumor necrosis factor-alpha levels and mortality from septic shock O. Appoloni, E. Dupont, M. Vandercruys, M. Andriens, J. Duchateau, JeanLouis Vincent Hypertriglyceridemia and other factors associated with plasma viscosity Robert S. Rosenson, Susan Shott, Liping Lu, Christine C. Tangney Diffuse non-hydrostatic, non-hypooncotic edema in autoimmune lupus-like disorders J. Oristrell, R. Pujol, M. Bosque, M.I. Moga, M.J. Amengual, D. Chivite, A. Casanovas, F. Mitjavila, J. de Nadal DIAGNOSTIC DILEMMA Prepared by Gretchen A.W. Gooding EDITORIALS Medical therapy for coronary artery disease works, even (especially) in the

434 -- 437

438 -- 441

442 -- 450

451 -- 457

458 -- 462

463 -- 470

471 -- 480

481 -- 485

486 -- 488

488 -- 492 492 -- 495

496 -- 496 497 -- 498

real world Michael S. Lauer Immunoglobulin a nephropathy with mild renal lesions: a call in the forest for physicians and nephrologists Francesco Paolo Schena Heparin therapy for deep vein thrombosis: from hospital to home Clive Kearon, Michael Gent CORRESPONDENCE Models of capitated payment for endstage renal disease: the reply Mark L. Zeidel, Srinivasan Beddhu Hyperthyroidism and criminal behavior Jean-Michel Petit, Sabine Rudoni, Jean-Fran ço is Cannard, Genevi ève Vaillant Cigarette lighter thumb Dale Maharaj, Vijay Naraynsingh APM VIEWS Internal medicine: at the nexus of the health care system in responding to the demographic imperative of an aging population William R. Hazzard, Nancy Woolard, Donna I. Regenstreif

499 -- 500

501 -- 502

504 -- 505 505 -- 506

506 -- 506

507 -- 513

VOL. 110, 6A SUPPLEMENT; 2001 Reaching National Cholesterol Education program Goals: A Managed Care Approach to Improving Hyperlipidemia Disease Management Outcomes Introduction Terry A. Jacobson Clinical context: Current concepts of coronary heart disease management Terry A. Jacobson A means to an end: An overview of a hyperlipidemia outcomes management program Barry Patel, H. Ed Perez Assessing the results: Phase 1 hyperlipidemia outcomes in 27 health plans Lisa M. Latts Lipid-lowering interventions in managed care settings Joseph Fox, Kenneth Jones

1 -- 2 3 -- 11 12 -- 16

17 -- 23 24 -- 30